P3 Health Partners (NASDAQ:PIII) Posts Quarterly Earnings Results, Misses Expectations By $0.28 EPS

P3 Health Partners (NASDAQ:PIII) released its quarterly earnings data on Tuesday. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.28), reports. The business had revenue of $362.12 million during the quarter, compared to analysts’ expectations of $368.60 million. P3 Health Partners had a negative return on equity of 67.63% and a negative net margin of 6.95%.

P3 Health Partners Stock Performance

Shares of NASDAQ:PIII opened at $0.25 on Thursday. The firm has a 50 day moving average of $0.41 and a 200 day moving average of $0.51. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $89.39 million, a price-to-earnings ratio of -0.30 and a beta of 1.15. P3 Health Partners has a 52 week low of $0.23 and a 52 week high of $1.78.

Insider Buying and Selling at P3 Health Partners

In related news, major shareholder Pacific Founders Ugp I. Chicago purchased 80,000 shares of P3 Health Partners stock in a transaction dated Wednesday, September 4th. The stock was purchased at an average cost of $0.49 per share, with a total value of $39,200.00. Following the transaction, the insider now owns 76,625,438 shares in the company, valued at approximately $37,546,464.62. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last 90 days, insiders have purchased 400,000 shares of company stock valued at $205,600. 17.86% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of PIII. Armistice Capital LLC purchased a new position in P3 Health Partners in the second quarter worth $3,557,000. Renaissance Technologies LLC grew its stake in P3 Health Partners by 188.1% during the 2nd quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after buying an additional 73,000 shares during the last quarter. Emfo LLC increased its position in P3 Health Partners by 39.8% during the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after buying an additional 406,418 shares in the last quarter. Finally, Sanders Morris Harris LLC increased its position in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after buying an additional 20,000 shares in the last quarter. Institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.